Barclays PLC Enanta Pharmaceuticals Inc Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Barclays PLC holds 45,508 shares of ENTA stock, worth $354,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,508
Previous 27,438
65.86%
Holding current value
$354,052
Previous $285,000
8.07%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$16.5 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$16.4 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$15.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$14.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$9.5 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $161M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...